Partnering for Successful Regenerative Medicine Projects in Australia

Join our workshop to explore Australia’s leading role in developing regenerative medicines, highlighting our robust cell and gene ecosystem, product development prowess, and the advantages of partnering with Australian CDMOs. Discover the strengths of Australian clinical trials, learn about the R&D tax incentive, and hear firsthand about successful Korean collaborations with Australia. This session, promoted through the Korea Association for Regenerative Medicine and other networks, aims to illuminate the opportunities for manufacturers and researchers in Korea within Australia’s vibrant regenerative medicine landscape.

What can you expect to learn at the workshop:

Australia’s Cell and Gene Ecosystem: An overview of Australia’s innovative environment for cell and gene therapies, showcasing its robust infrastructure and collaborative opportunities.

Product Development: Insights into the cutting-edge approaches and technologies driving regenerative medicine product development in Australia.

Why Use Australian CDMOs: Discover the competitive advantages of partnering with Australian Contract Development and Manufacturing Organizations (CDMOs) for regenerative medicine projects.

Clinical Trials: Understanding the strengths of Australia’s clinical trials landscape, including streamlined processes, supportive regulatory framework, and expertise in regenerative medicine trials.

Financial Incentives: Learn about the financial incentives available for research and development activities in Australia, making it an attractive location for regenerative medicine research.

Korean Experiences Working with Australia: Hear firsthand from Korean manufacturers and researchers about their successful collaborations and experiences working within Australia’s regenerative medicine sector.